Cargando…
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
BACKGROUND: TNBC is an aggressive subset of breast cancer (BC) without specific target therapy. METHODS: This observational, retrospective study included 45 cases of TNBC. The aim of this study was to evaluate the expression of the AR, E-cadherin and Ki-67 in relation to histological type, time to r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454487/ https://www.ncbi.nlm.nih.gov/pubmed/26039245 http://dx.doi.org/10.1371/journal.pone.0128368 |
_version_ | 1782374598186106880 |
---|---|
author | Ricciardi, Giuseppina Rosaria Rita Adamo, Barbara Ieni, Antonio Licata, Luana Cardia, Roberta Ferraro, Giuseppa Franchina, Tindara Tuccari, Giovanni Adamo, Vincenzo |
author_facet | Ricciardi, Giuseppina Rosaria Rita Adamo, Barbara Ieni, Antonio Licata, Luana Cardia, Roberta Ferraro, Giuseppa Franchina, Tindara Tuccari, Giovanni Adamo, Vincenzo |
author_sort | Ricciardi, Giuseppina Rosaria Rita |
collection | PubMed |
description | BACKGROUND: TNBC is an aggressive subset of breast cancer (BC) without specific target therapy. METHODS: This observational, retrospective study included 45 cases of TNBC. The aim of this study was to evaluate the expression of the AR, E-cadherin and Ki-67 in relation to histological type, time to relapse and overall survival (OS). Immunohistochemistry (IHC) was carried out on formalin-fixed paraffin-embedded tumor samples obtained from patients defined TNBC. RESULTS: The AR was positive (IHC >10%) in 26.6%. E-cadherin (CDH1) expression was considered positive if the score was ≥ 2. This expression was negative in 53.3% cases. The Ki-67 index was ≥ 20% in 37.7%. Univariate analyses showed that AR, CDH1 and Ki-67 are significantly associated with OS. Multivariate analysis showed that AR and Ki-67 expression are independent variables associated with OS. The statistical analysis showed that patients with AR negative and Ki-67 positive expression have a significant correlation with poor outcome. CONCLUSIONS: Our data suggest that the combination of AR and E-cadherin expression as well as Ki-67 status might be useful prognostic markers in TNBC. Hence, these molecular determinants could play an interesting role to classify subgroups of TNBC. |
format | Online Article Text |
id | pubmed-4454487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44544872015-06-09 Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients Ricciardi, Giuseppina Rosaria Rita Adamo, Barbara Ieni, Antonio Licata, Luana Cardia, Roberta Ferraro, Giuseppa Franchina, Tindara Tuccari, Giovanni Adamo, Vincenzo PLoS One Research Article BACKGROUND: TNBC is an aggressive subset of breast cancer (BC) without specific target therapy. METHODS: This observational, retrospective study included 45 cases of TNBC. The aim of this study was to evaluate the expression of the AR, E-cadherin and Ki-67 in relation to histological type, time to relapse and overall survival (OS). Immunohistochemistry (IHC) was carried out on formalin-fixed paraffin-embedded tumor samples obtained from patients defined TNBC. RESULTS: The AR was positive (IHC >10%) in 26.6%. E-cadherin (CDH1) expression was considered positive if the score was ≥ 2. This expression was negative in 53.3% cases. The Ki-67 index was ≥ 20% in 37.7%. Univariate analyses showed that AR, CDH1 and Ki-67 are significantly associated with OS. Multivariate analysis showed that AR and Ki-67 expression are independent variables associated with OS. The statistical analysis showed that patients with AR negative and Ki-67 positive expression have a significant correlation with poor outcome. CONCLUSIONS: Our data suggest that the combination of AR and E-cadherin expression as well as Ki-67 status might be useful prognostic markers in TNBC. Hence, these molecular determinants could play an interesting role to classify subgroups of TNBC. Public Library of Science 2015-06-03 /pmc/articles/PMC4454487/ /pubmed/26039245 http://dx.doi.org/10.1371/journal.pone.0128368 Text en © 2015 Ricciardi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Ricciardi, Giuseppina Rosaria Rita Adamo, Barbara Ieni, Antonio Licata, Luana Cardia, Roberta Ferraro, Giuseppa Franchina, Tindara Tuccari, Giovanni Adamo, Vincenzo Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title_full | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title_fullStr | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title_full_unstemmed | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title_short | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients |
title_sort | androgen receptor (ar), e-cadherin, and ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (tnbc) patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454487/ https://www.ncbi.nlm.nih.gov/pubmed/26039245 http://dx.doi.org/10.1371/journal.pone.0128368 |
work_keys_str_mv | AT ricciardigiuseppinarosariarita androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT adamobarbara androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT ieniantonio androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT licataluana androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT cardiaroberta androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT ferrarogiuseppa androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT franchinatindara androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT tuccarigiovanni androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients AT adamovincenzo androgenreceptorarecadherinandki67asemergingtargetsandnovelprognosticmarkersintriplenegativebreastcancertnbcpatients |